{"nctId":"NCT04704869","briefTitle":"Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation","startDateStruct":{"date":"2017-01","type":"ACTUAL"},"conditions":["Trauma Injury"],"count":1604,"armGroups":[{"label":"Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)","type":"EXPERIMENTAL","interventionNames":["Biological: Cryoprecipitate","Biological: Red Blood Cells","Biological: Plasma","Biological: Platelets","Biological: Whole Blood"]},{"label":"Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: Red Blood Cells","Biological: Plasma","Biological: Platelets","Biological: Whole Blood"]}],"interventions":[{"name":"Cryoprecipitate","otherNames":[]},{"name":"Red Blood Cells","otherNames":["RBCs"]},{"name":"Plasma","otherNames":[]},{"name":"Platelets","otherNames":[]},{"name":"Whole Blood","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The patient is judged to be an adult (according to local practice, e.g. 16 years or older in UK) and has sustained severe traumatic injury. In the event the age is unknown, estimated body weight â‰¥50 kg.\n* The patient is deemed by the attending clinician to have on-going active hemorrhage AND REQUIRES Activation of the local major hemorrhage protocol for management of severe blood loss AND HAS STARTED or HAS RECEIVED at least one unit of any blood component\n\nExclusion Criteria:\n\n* The patient has been transferred from another hospital\n* The trauma team leader deems the injuries incompatible with life\n* More than 3 hours have elapsed from the time of injury\n* Prisoner (as defined as someone admitted from a correctional facility)\n* Known \"Do Not Resuscitate\" orders\n* Enrolled in a concurrent ongoing interventional, randomized clinical trial\n* Patients who wear \"opt out\" bracelet for study\n* Obvious pregnancy\n* Severely burned","healthyVolunteers":false,"sex":"ALL","minimumAge":"16 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Mortality From Any Cause","description":"Mortality from any cause","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"201","spread":null},{"groupId":"OG001","value":"192","spread":null}]}]}]},{"type":"SECONDARY","title":"All Cause Mortality at 6 Hours","description":"Mortality from any cause","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"68","spread":null}]}]}]},{"type":"SECONDARY","title":"All Cause Mortality at 24 Hours","description":"Mortality from any cause","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null},{"groupId":"OG001","value":"97","spread":null}]}]}]},{"type":"SECONDARY","title":"All Cause Mortality at 6 Months","description":"Mortality from any cause. All cause mortality at 6 months is presented as a Kaplan-Meier estimated.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.1","spread":null},{"groupId":"OG001","value":"27.3","spread":null}]}]}]},{"type":"SECONDARY","title":"All Cause Mortality at 12 Months","description":"Mortality from any cause. All cause mortality at 6 months is presented as a Kaplan-Meier estimated.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.6","spread":null},{"groupId":"OG001","value":"27.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Death From Bleeding at 6 Hours","description":"Death related to exsanguination","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32","spread":null},{"groupId":"OG001","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Death From Bleeding at 24 Hours","description":"Death related to exsanguination","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null},{"groupId":"OG001","value":"39","spread":null}]}]}]},{"type":"SECONDARY","title":"Transfusion Requirements (Number of Units of Red Blood Cells (RBCs))","description":"Number of units of RBCs","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Transfusion Requirements (Number of Units of Plasma)","description":"Number of units of plasma","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Transfusion Requirements (Number of Units of Platelets)","description":"Number of units of platelets","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Transfusion Requirements (Number of Units of Cryoprecipitate)","description":"Number of units of cryoprecipitate","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Destination of Participant at Time of Discharge From Hospital","description":"Destination of participant at time of discharge from hospital","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"280","spread":null},{"groupId":"OG001","value":"278","spread":null}]},{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"8","spread":null}]},{"measurements":[{"groupId":"OG000","value":"63","spread":null},{"groupId":"OG001","value":"72","spread":null}]},{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"SECONDARY","title":"Quality of Life as Assessed by EuroQol-5 Dimension-5 Level (EQ5D-5L)","description":"The 5-level EQ-5D version (EQ-5D-5L) score range was -0.148 (worst health state) to 0.949 (best health state). A higher score indicating a better health state.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.51","spread":null},{"groupId":"OG001","value":"0.50","spread":null}]}]}]},{"type":"SECONDARY","title":"Quality of Life as Assessed by the Glasgow Outcome Score","description":"The Glasgow Outcome Score ranges from 1 to 5, with a higher score indicating a better outcome:\n\n1. Death - Severe injury or death without recovery of consciousness\n2. Persistent vegetative state - Severe damage with prolonged state of unresponsiveness and a lack of higher mental functions\n3. Severe disability - Severe injury with permanent need for help with daily living\n4. Moderate disability - No need for assistance in everyday life, employment is possible but may require special equipment\n5. Low disability - Light damage with minor neurological and psychological deficits","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"226","spread":null},{"groupId":"OG001","value":"221","spread":null}]},{"measurements":[{"groupId":"OG000","value":"129","spread":null},{"groupId":"OG001","value":"129","spread":null}]},{"measurements":[{"groupId":"OG000","value":"155","spread":null},{"groupId":"OG001","value":"153","spread":null}]},{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"27","spread":null}]},{"measurements":[{"groupId":"OG000","value":"174","spread":null},{"groupId":"OG001","value":"182","spread":null}]}]}]},{"type":"SECONDARY","title":"Quality of Life as Assessed by EuroQol-5 Dimension-5 Level (EQ5D-5L)","description":"The 5-level EQ-5D version (EQ-5D-5L) score range was -0.148 (worst health state) to 0.949 (best health state). A higher score indicating a better health state.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.76","spread":null},{"groupId":"OG001","value":"0.66","spread":null}]}]}]},{"type":"SECONDARY","title":"Quality of Life as Assessed by the Glasgow Outcome Score","description":"The Glasgow Outcome Score ranges from 1 to 5, with a higher score indicating a better outcome:\n\n1. Death - Severe injury or death without recovery of consciousness\n2. Persistent vegetative state - Severe damage with prolonged state of unresponsiveness and a lack of higher mental functions\n3. Severe disability - Severe injury with permanent need for help with daily living\n4. Moderate disability - No need for assistance in everyday life, employment is possible but may require special equipment\n5. Low disability - Light damage with minor neurological and psychological deficits","classes":[]},{"type":"SECONDARY","title":"Hospital Resource Use as Assessed by Number of Ventilator Days","description":"Number of ventilator days during hospitalization","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospital Resource Use as Assessed by Number of Intensive Care Unit (ICU) Days","description":"Number of ICU days during hospitalization","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospital Resource Use as Assessed by Number of Hospital Days","description":"Total number of hospital days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":83,"n":805},"commonTop":[]}}}